Download Biologics to Treat Substance Use Disorders: Vaccines, by Ivan D. Montoya PDF

By Ivan D. Montoya

This booklet is a systematic compendium documenting the cutting-edge within the discovery and improvement of vaccines, monoclonal antibodies, and enzymes for the therapy of Substance Use problems (SUDs). The ebook supplies targeted attention to a couple of the main innovative subject matters in dependancy drugs, together with vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies opposed to cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. furthermore, the textual content covers quite a lot of new suggestions designed to optimize the improvement and efficacy of biologics. in contrast to the other source, this e-book experiences how biologics provide fascinating new healing possibilities for varied psychiatric stipulations.

Written via specialists within the box, Biologics to regard Substance Use problems is as an authoritative reference for psychiatrists, psychologists, and all different doctors operating with sufferers being affected by Substance Use Disorders.

Show description

Read Online or Download Biologics to Treat Substance Use Disorders: Vaccines, Monoclonal Antibodies, and Enzymes PDF

Best pharmacology books

The Pharmacology of Alcohol and Drugs of Abuse and Addiction

This quantity is meant for clinicians, researchers, citizens, and scholars. the variety is huge and the intensity substantial for the entire issues lined within the remedy of this well timed and proper topic. This publication may perhaps serve both good as a basic creation and a scholarly reference. finally, it really is designed to serve these sufferers struggling with abuse of and dependancy to medicines and alcohol.

Artemisia annua - Pharmacology and Biotechnology

Artemisinin, a sesquiterpene lactone initially extracted from the medicinal plant Artemisia annua L. , is an efficient antimalarial agent, really for multi-drug resistant and cerebral malaria. although, the focus of artemisinin within the plant is especially low. as the chemical synthesis of artemisinin is complex and never economically possible in view of the negative yield of the drug, the intact plant continues to be the single achievable resource of artemisinin construction.

Blood-Brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs

Enthusiastic about critical apprehensive process (CNS) drug discovery efforts, this publication educates drug researchers in regards to the blood-brain barrier (BBB) to allow them to impact vital advancements in a single of the main major – and so much demanding – components of drug discovery. • Written through global specialists to supply sensible recommendations to extend mind penetration or reduce CNS side-effects• Reviews state of the art in silico, in vitro, and in vivo instruments to evaluate mind penetration and complicated CNS drug supply strategies• Covers BBB body structure, medicinal chemistry layout rules, loose drug speculation for the BBB, and delivery mechanisms together with passive diffusion, uptake/efflux transporters, and receptor-mediated processes• Highlights the advances in modelling BBB pharmacokinetics and dynamics relationships (PK/PD) and physiologically-based pharmacokinetics (PBPK)• Discusses case reviews of profitable CNS and non-CNS medications, classes discovered and paths to the marketplace

Managing the drug discovery process: how to make it more efficient and cost-effective

Coping with the Drug Discovery technique: how you can Make It extra effective and low cost completely examines the present kingdom of pharmaceutical study and improvement via offering chemistry-based views on biomedical examine, drug searching and innovation. The booklet additionally considers the interaction of stakeholders, shoppers, and the drug company with attendant elements, together with those who are technical, felony, fiscal, demographic, political, social, ecological, and infrastructural.

Extra resources for Biologics to Treat Substance Use Disorders: Vaccines, Monoclonal Antibodies, and Enzymes

Example text

Pfizer reported that the addition of the CpG TLR-agonist adjuvant to an analogue of NicVAX – 3’AmNic-DT – increased the reduction of nicotine brain levels in mice to 33 % as compared to placebo approximately tenfold over 3’AmNic-DT with alum only (3 %). Important differences exist between the 3’AmNic-DT utilized in the Pfizer mouse and NHP studies and the 3’AmNic-rEPA (NicVAX) utilized in the clinic: (a) rEPA is an alternative carrier protein and may lead to an enhanced immune response. (b) Direct comparison of the hapten density of the two vaccines utilizing the two different carriers was not conducted.

Can you vaccinate against substance abuse? Expert Opin Biol Ther. 2013;13(8):1093–7. Lindblom N, et al. Active immunization against nicotine prevents reinstatement of nicotineseeking behavior in rats. Respiration. 2002;69(3):254–60. Lockner JW, et al. A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacity J Med Chem. 2015 Jan 22;58(2):1005–11. Maurer P, et al. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and Immunogenicity.

PLoS One. 2013;8(10), e76557. Raupach T, Hoogsteder PHJ, van Schayck C. Nicotine vaccines to assist with smoking cessation: current status of research. Drugs. 2012;72(4):e1–16. Roiko SA, Harris AC, Keyler DE, Lesage MG, Zhang Y, Pentel PR. Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats. J Pharmacol Exp Ther. 2008;325(3):985–93. Selecta Biosciences. Selecta biosciences: technology platform. [Online]. 2015. cfm. Accessed 5 July 2015. Stitzer M, de Wit H.

Download PDF sample

Rated 4.93 of 5 – based on 30 votes